These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7896499

  • 1. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL, Schmitter SJ, Bouzit H, Johnson TW, Hepp AM, Kurtz KR, Mousigian C.
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [Abstract] [Full Text] [Related]

  • 2. Conformationally restricted deltorphin analogues.
    Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C.
    J Med Chem; 1992 Oct 16; 35(21):3956-61. PubMed ID: 1331451
    [Abstract] [Full Text] [Related]

  • 3. Modification of the Phe3 aromatic moiety in delta receptor-selective dermorphin/deltorphin-related tetrapeptides. Effects on opioid receptor binding.
    Heyl DL, Mosberg HI.
    Int J Pept Protein Res; 1992 May 16; 39(5):450-7. PubMed ID: 1330964
    [Abstract] [Full Text] [Related]

  • 4. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S, Sagan S, Delfour A, Nicolas P.
    Biochem Biophys Res Commun; 1991 Sep 30; 179(3):1161-8. PubMed ID: 1656944
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
    Breveglieri A, Guerrini R, Salvadori S, Bianchi C, Bryant SD, Attila M, Lazarus LH.
    J Med Chem; 1996 Feb 02; 39(3):773-80. PubMed ID: 8576920
    [Abstract] [Full Text] [Related]

  • 6. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
    Bryant SD, Guerrini R, Salvadori S, Bianchi C, Tomatis R, Attila M, Lazarus LH.
    J Med Chem; 1997 Aug 01; 40(16):2579-87. PubMed ID: 9258365
    [Abstract] [Full Text] [Related]

  • 7. Opioid receptor binding requirements for the delta-selective peptide deltorphin. I: Phe3 replacement with ring-substituted and heterocyclic amino acids.
    Heyl DL, Dandabathula M, Kurtz KR, Mousigian C.
    J Med Chem; 1995 Mar 31; 38(7):1242-6. PubMed ID: 7707326
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Omnaas JR, Lomize A, Heyl DL, Nordan I, Mousigian C, Davis P, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4384-91. PubMed ID: 7996550
    [Abstract] [Full Text] [Related]

  • 10. Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides.
    Guis C, Bruetschy L, Meudal H, Roques BP, Gacel GA.
    Int J Pept Protein Res; 1993 Jun 09; 41(6):576-86. PubMed ID: 8394291
    [Abstract] [Full Text] [Related]

  • 11. Bioactivity of new mu and delta opioid peptides.
    Capasso A.
    Med Chem; 2007 Sep 09; 3(5):480-7. PubMed ID: 17897075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Lomize AL, Wang C, Kroona H, Heyl DL, Sobczyk-Kojiro K, Ma W, Mousigian C, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4371-83. PubMed ID: 7996549
    [Abstract] [Full Text] [Related]

  • 14. pKa and volume of residue one influence delta/mu opioid binding: QSAR analysis of tyrosine replacement in a nonselective deltorphin analogue.
    Heyl DL, Schullery SE, Renganathan K, Jayamaha MN, Rodgers DW, Traynor JR.
    Bioorg Med Chem; 2003 Aug 15; 11(17):3761-8. PubMed ID: 12901921
    [Abstract] [Full Text] [Related]

  • 15. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
    Segawa M, Ohno Y, Doi M, Inoue M, Ishida T, Iwashita T.
    Int J Pept Protein Res; 1994 Sep 15; 44(3):295-304. PubMed ID: 7822107
    [Abstract] [Full Text] [Related]

  • 16. Para-substituted Phe3 deltorphin analogues: enhanced selectivity of halogenated derivatives for delta opioid receptor sites.
    Salvadori S, Bianchi C, Lazarus LH, Scaranari V, Attila M, Tomatis R.
    J Med Chem; 1992 Dec 11; 35(25):4651-7. PubMed ID: 1335080
    [Abstract] [Full Text] [Related]

  • 17. Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors.
    Lazarus LH, Salvadori S, Balboni G, Tomatis R, Wilson WE.
    J Med Chem; 1992 Apr 03; 35(7):1222-7. PubMed ID: 1313878
    [Abstract] [Full Text] [Related]

  • 18. [D-Ala2]deltorphin II analogs with high affinity and selectivity for delta-opioid receptor.
    Sasaki Y, Ambo A, Suzuki K.
    Biochem Biophys Res Commun; 1991 Oct 31; 180(2):822-7. PubMed ID: 1659404
    [Abstract] [Full Text] [Related]

  • 19. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Marsden BJ, Wilkes BC.
    J Med Chem; 1991 Oct 31; 34(10):3125-32. PubMed ID: 1656045
    [Abstract] [Full Text] [Related]

  • 20. Modifications of the cyclic mu receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]NH2 (Et): effects on opioid receptor binding and activation.
    McFadyen IJ, Ho JC, Mosberg HI, Traynor JR.
    J Pept Res; 2000 Mar 31; 55(3):255-61. PubMed ID: 10727108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.